Key result
Expedited invasive strategy lacks sufficient evidence to support routine use in NACS.
Why the study?
The optimal timing of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndromes remains uncertain due to limited and mainly observational data.
Does an expedited invasive strategy improve outcomes compared to deferred angiography in patients with high-risk non-ST-segment elevation acute coronary syndromes?
Does an expedited invasive strategy improve outcomes compared to deferred angiography in patients with high-risk non-ST-segment elevation acute coronary syndromes?
Answers are grounded in this paper and cite their sources.
Current evidence is insufficient to recommend a routine expedited invasive strategy for high-risk NSTE-ACS, though it remains a viable approach.
PURPOSE OF REVIEW: This review describes available data on the optimal timing of an early invasive strategy in patients with high-risk non-ST-segment elevation acute coronary syndromes, along with challenges with type of studies. We also discuss the implication of timing in the overall management of the non-ST-segment elevation acute coronary syndrome patients. RECENT FINDINGS: The issue of timing of the coronary angiography has been addressed mainly with observational analyses. The only, small, randomized clinical trial, the Intracoronary Stenting With Antithrombotic Regimen Cooling-Off, indicated a superiority of an expedited approach compared with a much deferred angiography. A recent observational analysis adopting special statistical methodologies confirmed the finding of the Intracoronary Stenting With Antithrombotic Regimen Cooling-Off trial in patients undergoing an early invasive strategy in the first 48 h of presentation. SUMMARY: Current evidence is not sufficient to recommend the use of a routine expedite invasive strategy but suggests that it may be a viable approach.
No takes yet. Share an insight, caveat, or question.
Pierluigi Tricoci (2008) conducted a review in high-risk non-ST-segment elevation acute coronary syndromes. Expedited invasive strategy (early coronary angiography) vs. Deferred angiography was evaluated. An expedited invasive strategy for non-ST-segment elevation acute coronary syndrome may be a viable approach, though current evidence is insufficient to recommend its routine use.
Synapse has enriched 10 related papers. Consider them for comparative context: